Cocrystal Pharma, Inc.
COCP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412486
In the last 90 days, Cocrystal Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.17M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Cocrystal Pharma, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 24 | 24 | 0 |
| Shares | 711.4K | 748.8K | +37.4K (+5.3%) |
| Value | $1.44M | $1.06M | −$373.0K (−26.0%) |
New holders (2)
Institutions that held Cocrystal Pharma, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Neuberger Berman Group LLC | 59,271 | $84.2K | 0.00% |
| Citadel Advisors LLC | 10,034 | $14.2K | 0.00% |
Sold out (2)
Institutions that held Cocrystal Pharma, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Velan Capital Investment Management LP | 10,000 | $20.2K |
| Citigroup Inc | 3 | $6 |